Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of Severe COVID-19 in Prevalent Users of Alpha-1 Adrenergic Receptor Antagonists: A National Case-Control Study of Medicare Beneficiaries

Published:2023-10 Issue:10 Volume:136 Page:1018-1025.e3
ISSN:0002-9343
Container-title:The American Journal of Medicine
language:en
Short-container-title:The American Journal of Medicine

Author:

Graham David J.^ORCID,Izurieta Hector S.,Zhang Di,Avagyan Armen,Lyu Hai,Wiederhorn Roger,Lu Yun,Mosholder Andrew D.,Smith Elizabeth R.,Zhao Yueqin,Shangguan Shanlai,Tsai Huei-Ting,Pennap Dinci,Sandhu Alexander T.,Wernecke Michael,MaCurdy Thomas E.,Kelman Jeffrey A.,Forshee Richard A.

Funder

Centers for Medicare and Medicaid Services

U.S. Food and Drug Administration

Publisher

Elsevier BV

Subject

General Medicine

Reference31 articles.

1. Clinical and immunological features of severe and moderate coronavirus disease 2019;Chen;J Clin Invest.,2020

2. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study;Zhou;Lancet.,2020

3. Pathological findings of COVID-19 associated with acute respiratory distress syndrome;Xu;Lancet Respir Med.,2020

4. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet.,2020

5. Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists;Konig;J Clin Invest.,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP